Updated on June 25, 2025 The Ax-4 mission — Axiom Space’s fourth commercial astronaut flight to the International Space Station launched on June 25, 2025, and we’re thrilled to announce that TrialX is once again playing…
2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S – introducing high-impact therapies that are redefining what “breakthrough” truly means. This year’s portfolio highlights durable formulations…
Obesity has rapidly become one of the world’s most urgent health challenges, now affecting over 1 billion people globally, including 159 million children, according to a study published by The Lancet. With continued prevention and treatment…
🦃 This holiday season, we’re especially grateful for partnerships that bring hope to patients and families. We are honored to power the AI-based clinical trial finder for ALK Positive, a patient-driven organization dedicated to improving the…
In 2022, OpenAI launched its first large-scale AI tool—an innovation that quickly reshaped how industries approached automation, creativity, and problem-solving. Since then, artificial intelligence has become part of everyday workflows, turning time-intensive tasks into faster, data-driven…
Pancreatic cancer is one of the most challenging cancers to diagnose and treat. Often called a “silent killer,” it rarely shows symptoms until it reaches an advanced stage — when treatment options become limited. Despite being…
Diabetes Awareness Month is a reminder of what life with diabetes really looks like—daily decisions, routines, and small adjustments that never take a day off. The theme for 2024–2026, “Diabetes and Well-being,” focuses on the physical,…
How can astronauts stay safe when life-support systems are aging and data monitoring is fragmented? A recent NASA audit has reignited discussion about space health research. It focuses on one of the most vital systems keeping…
